A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study.
Saved in:
| Title: | A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study. |
|---|---|
| Authors: | Xicheng, Wang1 (AUTHOR), Yanhong, Deng2 (AUTHOR), Yanqiao, Zhang3 (AUTHOR), Tianshu, Liu4 (AUTHOR), Xianglin, Yuan5 (AUTHOR), Jianwei, Yang6 (AUTHOR), Tao, Zhang5 (AUTHOR), Aimin, Zang7 (AUTHOR), Yu, Liu8 (AUTHOR), Li, Huang9 (AUTHOR), Feng, Ye10 (AUTHOR), Hong, Zong11 (AUTHOR), Yi, Ba12 (AUTHOR), Isabelle, Klauck13 (AUTHOR), Jean‐Claude, Vedovato13 (AUTHOR), Mélanie, Groc13 (AUTHOR), Angela, Guo14 (AUTHOR), Jian, Li1 (AUTHOR) oncogene@163.com, Lin, Shen1 (AUTHOR) |
| Source: | Cancer Medicine. Mar2026, Vol. 15 Issue 3, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 192505952 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAF<superscript>V600E</superscript> Mutant Metastatic Colorectal Cancer: The NAUTICAL Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Xicheng%2C+Wang%22">Xicheng, Wang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yanhong%2C+Deng%22">Yanhong, Deng</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yanqiao%2C+Zhang%22">Yanqiao, Zhang</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tianshu%2C+Liu%22">Tianshu, Liu</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xianglin%2C+Yuan%22">Xianglin, Yuan</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jianwei%2C+Yang%22">Jianwei, Yang</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tao%2C+Zhang%22">Tao, Zhang</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aimin%2C+Zang%22">Aimin, Zang</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Liu%22">Yu, Liu</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Huang%22">Li, Huang</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feng%2C+Ye%22">Feng, Ye</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hong%2C+Zong%22">Hong, Zong</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yi%2C+Ba%22">Yi, Ba</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Isabelle%2C+Klauck%22">Isabelle, Klauck</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jean‐Claude%2C+Vedovato%22">Jean‐Claude, Vedovato</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mélanie%2C+Groc%22">Mélanie, Groc</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Angela%2C+Guo%22">Angela, Guo</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jian%2C+Li%22">Jian, Li</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> oncogene@163.com</i><br /><searchLink fieldCode="AR" term="%22Lin%2C+Shen%22">Lin, Shen</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Mar2026, Vol. 15 Issue 3, p1-13. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192505952 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cam4.71697 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 1 Titles: – TitleFull: A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xicheng, Wang – PersonEntity: Name: NameFull: Yanhong, Deng – PersonEntity: Name: NameFull: Yanqiao, Zhang – PersonEntity: Name: NameFull: Tianshu, Liu – PersonEntity: Name: NameFull: Xianglin, Yuan – PersonEntity: Name: NameFull: Jianwei, Yang – PersonEntity: Name: NameFull: Tao, Zhang – PersonEntity: Name: NameFull: Aimin, Zang – PersonEntity: Name: NameFull: Yu, Liu – PersonEntity: Name: NameFull: Li, Huang – PersonEntity: Name: NameFull: Feng, Ye – PersonEntity: Name: NameFull: Hong, Zong – PersonEntity: Name: NameFull: Yi, Ba – PersonEntity: Name: NameFull: Isabelle, Klauck – PersonEntity: Name: NameFull: Jean‐Claude, Vedovato – PersonEntity: Name: NameFull: Mélanie, Groc – PersonEntity: Name: NameFull: Angela, Guo – PersonEntity: Name: NameFull: Jian, Li – PersonEntity: Name: NameFull: Lin, Shen IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 20457634 Numbering: – Type: volume Value: 15 – Type: issue Value: 3 Titles: – TitleFull: Cancer Medicine Type: main |
| ResultId | 1 |